Best Diagnostic & Research Stocks to Buy Now (2024)Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.
Industry: Diagnostics & Research
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| ICLR | ICON PLC | Ireland | $26.02B | 82,683,805 | 92.95% | 0.00% | ||
| STRR | STAR EQUITY HOLDINGS INC | United States | $13.95M | 15,848,202 | 3.59% | 96.41% | Net Buying | Net Selling |
| FONR | FONAR CORP | United States | $102.27M | 6,710,807 | 46.58% | 3.51% | ||
| TMO | THERMO FISHER SCIENTIFIC INC | United States | $227.24B | 381,716,323 | 86.41% | 0.88% | Net Selling | Net Selling |
| IDXX | IDEXX LABORATORIES INC | United States | $44.88B | 82,587,328 | 86.09% | 1.69% | Net Buying | Net Buying |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | United States | $11.42B | 51,511,687 | 96.77% | 3.23% | Net Selling | Net Selling |
| ENZ | ENZO BIOCHEM INC | United States | $55.84M | 51,225,734 | 26.98% | 48.12% | Net Selling | |
| DGX | QUEST DIAGNOSTICS INC | United States | $16.03B | 111,091,574 | 87.28% | 1.76% | Net Selling | Net Selling |
| MEDP | MEDPACE HOLDINGS INC | United States | $12.19B | 30,983,399 | 27.68% | 72.32% | Net Selling | Net Selling |
| SHC | SOTERA HEALTH CO | United States | $3.20B | 283,070,826 | 62.45% | 37.55% | Net Selling | Net Selling |
| NEOG | NEOGEN CORP | United States | $2.93B | 216,607,746 | 98.48% | 1.52% | Net Buying | Net Buying |
| LAB | STANDARD BIOTOOLS INC | United States | $956.40M | 372,141,530 | 71.30% | 26.00% | Net Buying | Net Buying |
| A | AGILENT TECHNOLOGIES INC | United States | $45.20B | 293,055,284 | 87.26% | 1.19% | Net Buying | Net Selling |
| QGEN | QIAGEN NV | Netherlands | $10.23B | 223,904,000 | 58.64% | 0.00% | ||
| DHR | DANAHER CORP | United States | $196.87B | 740,686,541 | 75.77% | 24.23% | Net Selling | Net Selling |
| FLGT | FULGENT GENETICS INC | United States | $661.63M | 29,924,288 | 41.89% | 58.11% | Net Selling | Net Selling |
| SERA | SERA PROGNOSTICS INC | United States | $269.72M | 32,653,777 | 44.13% | 20.95% | Net Selling | Net Selling |
| CSTL | CASTLE BIOSCIENCES INC | United States | $669.20M | 27,607,183 | 84.88% | 15.12% | Net Selling | Net Selling |
| EXAS | EXACT SCIENCES CORP | United States | $9.30B | 184,529,721 | 87.59% | 3.27% | Net Selling | Net Selling |
| NTRA | NATERA INC | United States | $13.07B | 122,802,694 | 78.93% | 21.07% | Net Selling | Net Buying |
| PRE | PRENETICS GLOBAL LTD | Hong Kong | $70.84M | 12,205,200 | 21.37% | 0.00% | ||
| RVTY | REVVITY INC | United States | $13.60B | 123,392,991 | 84.12% | 2.55% | Net Buying | Net Selling |
| CHEK | CHECK-CAP LTD | Israel | $12.78M | 5,850,770 | 0.11% | 0.00% | ||
| OLK | OLINK HOLDING AB (PUBL) | Sweden | $2.98B | 124,342,715 | 30.80% | 0.00% | ||
| LH | LABCORP HOLDINGS INC | United States | $17.75B | 84,293,628 | 91.75% | 1.52% | Net Selling | Net Selling |
| WAT | WATERS CORP | United States | $21.11B | 59,319,699 | 92.29% | 7.71% | Net Selling | Net Selling |
| PRPO | PRECIPIO INC | United States | $9.24M | 1,469,540 | 0.50% | 99.50% | Net Buying | Net Buying |
| DRIO | DARIOHEALTH CORP | Israel | $56.85M | 29,923,250 | 29.90% | 53.11% | ||
| NEO | NEOGENOMICS INC | United States | $1.89B | 127,711,930 | 72.34% | 27.66% | Net Selling | Net Selling |
| TWST | TWIST BIOSCIENCE CORP | United States | $2.74B | 58,225,999 | 88.30% | 11.70% | Net Selling | Net Selling |
| IQV | IQVIA HOLDINGS INC | United States | $42.12B | 182,200,000 | 53.14% | 46.86% | Net Selling | Net Selling |
| MTD | METTLER TOLEDO INTERNATIONAL INC | United States | $32.52B | 21,357,370 | 93.09% | 4.54% | Net Selling | Net Buying |
| BNR | BURNING ROCK BIOTECH LTD | China | $85.03M | 102,440,448 | 20.16% | 0.00% | ||
| ACRS | ACLARIS THERAPEUTICS INC | United States | $84.81M | 71,264,786 | 55.08% | 44.92% | Net Selling | Net Selling |
| RDNT | RADNET INC | United States | $4.24B | 73,880,145 | 67.02% | 32.98% | Net Selling | |
| CDNA | CAREDX INC | United States | $807.30M | 52,083,792 | 78.99% | 21.01% | Net Selling | Net Buying |
| PSNL | PERSONALIS INC | United States | $72.71M | 51,938,839 | 42.83% | 17.87% | Net Selling | Net Buying |
| STIM | NEURONETICS INC | United States | $78.29M | 29,997,563 | 52.75% | 47.25% | Net Selling | Net Selling |
| ME | 23ANDME HOLDING CO | United States | $283.47M | 482,916,636 | 25.40% | 2.59% | Net Buying | Net Selling |
| GH | GUARDANT HEALTH INC | United States | $3.10B | 122,369,214 | 64.07% | 35.93% | Net Buying | Net Buying |
| XWEL | XWELL INC | United States | $7.28M | 4,183,435 | 1.38% | 98.62% | Net Buying | |
| OCX | ONCOCYTE CORP | United States | $39.16M | 13,364,637 | 5.72% | 94.28% | Net Buying | Net Buying |
| MYGN | MYRIAD GENETICS INC | United States | $2.29B | 90,507,981 | 92.82% | 7.18% | Net Selling | Net Selling |
| DMTK | DERMTECH INC | United States | $17.45M | 34,962,994 | 12.14% | 76.98% | Net Selling | Net Selling |
| XGN | EXAGEN INC | United States | $32.66M | 17,373,482 | 35.48% | 64.52% | Net Buying | Net Buying |
| PRPH | PROPHASE LABS INC | United States | $95.97M | 19,078,529 | 8.91% | 54.08% | ||
| AWH | ASPIRA WOMEN's HEALTH INC | United States | $33.12M | 12,449,512 | 2.19% | 97.81% | Net Buying | |
| NDRA | ENDRA LIFE SCIENCES INC | United States | $3.39M | 11,035,659 | 2.08% | 8.73% | ||
| VNRX | VOLITIONRX LTD | United States | $63.77M | 82,815,121 | 9.40% | 39.76% | Net Buying | Net Selling |
| MDXH | MDXHEALTH SA | Belgium | $7.86M | 27,288,093 | 11.51% | 88.49% | ||
| GENE | GENETIC TECHNOLOGIES LTD | Australia | $526.30k | 115,417,246 | 0.06% | 0.00% | ||
| NOTV | INOTIV INC | United States | $50.12M | 25,971,450 | 25.19% | 43.41% | Net Buying | |
| BIAF | BIOAFFINITY TECHNOLOGIES INC | United States | $26.35M | 11,657,537 | 2.01% | 36.86% | Net Buying | Net Buying |
| MYNZ | MAINZ BIOMED NV | Germany | $14.39M | 21,165,482 | 0.69% | 0.00% | ||
| ILMN | ILLUMINA INC | United States | $17.69B | 159,300,000 | 89.03% | 1.99% | Net Selling | Net Buying |
| OPK | OPKO HEALTH INC | United States | $920.03M | 696,991,677 | 16.30% | 83.70% | Net Buying | Net Buying |
| PMD | PSYCHEMEDICS CORP | United States | $14.98M | 5,805,611 | 20.81% | 49.61% | Net Selling | |
| APDN | APPLIED DNA SCIENCES INC | United States | $2.47M | 984,728 | 17.77% | 82.23% | ||
| TRIB | TRINITY BIOTECH PLC | Ireland | $12.11M | 153,310,284 | 1.91% | 0.00% | ||
| BDSX | BIODESIX INC | United States | $180.63M | 114,685,783 | 13.96% | 61.11% | Net Buying | Net Selling |
| MMA | ALTA GLOBAL GROUP LTD | Australia | N/A | 10,223,079 | 0.00% | 0.00% | ||
| ISPC | ISPECIMEN INC | United States | $2.40M | 9,978,958 | 3.00% | 64.70% | Net Buying | |
| TTOO | T2 BIOSYSTEMS INC | United States | $49.59M | 8,792,950 | 0.32% | 99.68% | Net Selling | |
| CNTG | CENTOGENE NV | Germany | $10.21M | 27,595,835 | 7.76% | 0.00% |
Diagnostic & Research Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.